Salivary Immunoglobulin A (sIgA) Normal Range Study

Study to Survey the Normal Range of Salivary Immunoglobulin A (sIgA) Levels Measured by a Point of Care Device in Healthy Adult Women and Men

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06248788

Acronym

sIgA

Enrollment

Registered

2024-02-08

Start date

2017-06-19

Completion date

2018-01-20

Last updated

2024-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Salivary Immunity

Keywords

salivary immunoglobulin A, point of care device

Brief summary

Salivary Immunoglobulin A (sIgA) is a marker of immune system activity. Typically, sIgA is determined by an ELISA test in which samples have to be sent to a specialized laboratory for testing. Investigators have developed a new instrument that is small, portable, and easy to use. This instrument is available for consumers to purchase and test their own sIgA at home.

Interventions

DEVICEPoC Device

PoC Device for Testing Salivary IgA

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Adults committed to attend the session and follow the instructions described in Experimental Design will be included.

Exclusion criteria

* Participant with mouth infection or oral disease

Design outcomes

Primary

Measure	Time frame
Salivary IgA	0 minute

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026